rhDNase as an example of recurrent event analysisTHERNEAU, T. M; HAMILTON, S. A.Statistics in medicine. 1997, Vol 16, Num 18, pp 2029-2047, issn 0277-6715Article

Long-term trends in hip fracture prevalence : The influence of hip fracture incidence and survivalMELTON, L. J; THERNEAU, T. M; LARSON, D. R et al.Osteoporosis international. 1998, Vol 8, Num 1, pp 68-74, issn 0937-941XArticle

Normalization of two-channel microarray experiments: a semiparametric approachECKEL, J. E; GENNINGS, C; THERNEAU, T. M et al.Bioinformatics (Oxford. Print). 2005, Vol 21, Num 7, pp 1078-1083, issn 1367-4803, 6 p.Article

A revised natural history model for primary sclerosing cholangitisKIM, W. R; THERNEAU, T. M; WIESNER, R. H et al.Mayo Clinic proceedings. 2000, Vol 75, Num 7, pp 688-694, issn 0025-6196Article

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis : a randomized trialANGULO, P; DICKSON, E. R; THERNEAU, T. M et al.Journal of hepatology. 1999, Vol 30, Num 5, pp 830-835, issn 0168-8278Article

Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota Breast Cancer FamiliesSELLERS, T. A; KING, R. A; THERNEAU, T. M et al.Cancer epidemiology, biomarkers & prevention. 1999, Vol 8, Num 12, pp 1051-1057, issn 1055-9965Article

Increased risk of chronic liver failure in adults with heterozygous α₁-Antitrypsin deficiencyGRAZIADEI, I. W; JOSEPH, J. J; WIESNER, R. H et al.Hepatology (Baltimore, Md.). 1998, Vol 28, Num 4, pp 1058-1063, issn 0270-9139Article

Cost-effectiveness of 6 and 12 months of interferon-α therapy for chronic hepatitis CKIM, W. R; POTERUCHA, J. J; HERMANS, J. E et al.Annals of internal medicine. 1997, Vol 127, Num 10, pp 866-874, issn 0003-4819Article

Time course of histological progression in primary biliary cirrhosisLOCKE, G. R; THERNEAU, T. M; LUDWIG, J et al.Hepatology (Baltimore, Md.). 1996, Vol 23, Num 1, pp 52-56, issn 0270-9139Conference Paper

Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometryWINKLER, H. Z; RAINWATER, L. M; MYERS, R. P et al.Mayo Clinic proceedings. 1988, Vol 63, Num 2, pp 103-112, issn 0025-6196Article

Designs for group sequential phase II clinical trialsCHANG, M. N; THERNEAU, T. M; WIEAND, H. S et al.Biometrics. 1987, Vol 43, Num 4, pp 865-874, issn 0006-341XArticle

Secular trends in hip fracture incidence and recurrenceMELTON, L. J; KEARNS, A. E; ATKINSON, E. J et al.Osteoporosis international. 2009, Vol 20, Num 5, pp 687-694, issn 0937-941X, 8 p.Article

Human leukocyte antigen DR markers as predictors of progression to liver transplantation in patients with chronic hepatitis CBRANDHAGEN, D. J; GROSS, J. B; GORDON, F. D et al.The American journal of gastroenterology. 2000, Vol 95, Num 8, pp 2056-2060, issn 0002-9270Article

Time course of histological progression in primary sclerosing cholangitisANGULO, P; LARSON, D. R; THERNEAU, T. M et al.The American journal of gastroenterology. 1999, Vol 94, Num 11, pp 3310-3313, issn 0002-9270Article

Beta₂-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myelomaRAJKUMAR, S. V; FONSECA, R; LACY, M. Q et al.Bone marrow transplantation (Basingstoke). 1999, Vol 23, Num 12, pp 1261-1266, issn 0268-3369Article

Hepatic retransplantation in cholestatic liver disease : Impact of the interval to retransplantation on survival and resource utilizationKIM, W. R; WIESNER, R. H; KROM, R. A. F et al.Hepatology (Baltimore, Md.). 1999, Vol 30, Num 2, pp 395-400, issn 0270-9139Article

Incidence of cancer in primary biliary cirrhosis : The Mayo ExperienceNIJHAWAN, P. K; THERNEAU, T. M; DICKSON, E. R et al.Hepatology (Baltimore, Md.). 1999, Vol 29, Num 5, pp 1396-1398, issn 0270-9139Article

Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acidANGULO, P; LINDOR, K. D; THERNEAU, T. M et al.Liver (Copenhagen). 1999, Vol 19, Num 2, pp 115-121, issn 0106-9543Article

Bone disease in patients with primary sclerosing cholangitis : prevalence, severity and prediction of progressionANGULO, P; THERNEAU, T. M; JORGENSEN, R. A et al.Journal of hepatology. 1998, Vol 29, Num 5, pp 729-735, issn 0168-8278Article

Optimal timing of liver transplantation for primary biliary cirrhosisKIM, W. R; WIESNER, R. H; THERNEAU, T. M et al.Hepatology (Baltimore, Md.). 1998, Vol 28, Num 1, pp 33-38, issn 0270-9139Article

Chromosomal abnormalities in systemic amyloidosisFONSECA, R; AHMANN, G. J; JALAL, S. M et al.British journal of haematology. 1998, Vol 103, Num 3, pp 704-710, issn 0007-1048Article

Chronic myelomonocytic leukemia : natural history and prognostic determinantsTEFFERI, A; CLARK HOAGLAND, H; THERNEAU, T. M et al.Mayo Clinic proceedings. 1989, Vol 64, Num 10, pp 1246-1254, issn 0025-6196, 9 p.Article

No routine role for vincristine, adriamycin, and cyclophosphamide (VAC) or thoracic radiation therapy on extensive stage small cell lung cancerEAGAN, R. T; FRYTAK, S; LEE, R. E et al.American journal of clinical oncology. 1987, Vol 10, Num 2, pp 141-145, issn 0277-3732Article

Serial acquisition of data to predict one-year mortality rate after acute myocardial infarctionTIBBITS, P. A; EVAUL, J. E; GOLDSTEIN, R. E et al.The American journal of cardiology. 1987, Vol 60, Num 7, pp 451-455, issn 0002-9149Article

Iron overload in cirrhosis : HFE genotypes and outcome after liver transplantationBRANDHAGEN, D. J; ALVAREZ, W; THERNEAU, T. M et al.Hepatology (Baltimore, Md.). 2000, Vol 31, Num 2, pp 456-460, issn 0270-9139Article